Overview of Total Cholesterol Levels in Prolanis Hypertensive Patients at the Kelapa Dua Community Health Center
DOI:
https://doi.org/10.61843/jondpac.v3i2.1000Keywords:
Prolanis, Hypertension, Total CholesterolAbstract
Hypertension is one of the non-communicable diseases whose prevalence continues to increase each year and contributes substantially to the risk of cardiovascular disease, especially when accompanied by high total cholesterol levels. This study aimed to describe total cholesterol levels among hypertensive patients participating in the Chronic Disease Management Program (Prolanis) at the Kelapa Dua Community Health Center, Tangerang Regency. This study used a descriptive design with a cross-sectional approach, and the sample consisted of 25 hypertensive Prolanis patients at the Kelapa Dua Community Health Center. Total cholesterol was examined using the CHOD-PAP method. The results showed that borderline-high total cholesterol levels by age were most common in the middle-aged group (45-59 years), with 7 respondents (64%), while 4 respondents (80%) had high cholesterol levels. Based on sex, high total cholesterol levels were found in 10 female respondents (91%) and 1 male respondent (9%). Based on the classification of total cholesterol levels by hypertension category, high total cholesterol was most frequently found in grade 1 hypertension, with 5 respondents (63%), while borderline-high cholesterol was found in 3 respondents (33%).
Downloads
References
Amalia, L. (2020) Gambaran Kejadian Hipertensi Di Dusun Pameungpeuk Desa Cikunir Kecamatan Singaparna Tahun 2018.
Angraeni, N. (2020) Distribusi Penderita Hipertensi Berdasarkan Faktor Risiko.
Ekasari, M.F. et al. (2021) Kenali Penyebab, Tanda Gejala Dan Penangannya.
Fahreza, F. et al. (2020) Gambaran Kadar Total Kolesterol Pada Pasien Prolanis Yang Mendapat Terapi Simvastatin Di Puskesmas Air Dingin 2018, Ibnu Sina: Jurnal Kedokteran dan Kesehatan - Fakultas Kedokteran Universitas Islam Sumatera Utara.
Indasah and Utama, R.D. (2021) Kolesterol Dan Penanganannya, Strada Press.
Kemenkes, U. (2019) Mengenal Penyakit Hipertensi.
Kesehatan, B.K.P. (2023) Survei Kesehatan Indonesia. Survei Kesehatan Indonesia (SKI).
Kurniawan, D.A. and Tukiran, T. (2021) Aktivitas Antihiperkolesterolemia Dari Secang (Caesalpinia sappan L.).
Nurizky, G.P. (2023) Gambaran Kadar Kolesterol Total Pada Pasien Prolanis Hipertensi Di Rumah Sakit Melati Kota Tangerang Tahun 2024.
Nuswantoro, A., Aprillia, D. and Cristyaningsih, J. (2023) Lipid Profile of Prolanis Patients in Pontianak City.
Pebiani, P. (2024) Analisis kualitas hidup pasien hipertensi anggota prolanis Puskesmas Gamping 2.
Permatasari, R., Suriani, E. and Kurniawan (2022) Hubungan Kadar Kolesterol Total Dengan Tekanan Darah Pada Pasien Hipertensi pada Usia ≥ 40 Tahun. Jurnal Labora Medika.
Pratiwi, G. (2022) Hubungan Antara Kadar Kolesterol Total Dengan Kadar High Sensitivity C-Reactive Protein (Hs-Crp) Pada Penderita Diabetes Mellitus Tipe 2.
Purnamasari, R.P. and Indriastuti, D. (2020) Kadar Kolesterol Total Pada Penderita Hipertensi Usia Pra Lansia.
RI, K. (2019) Nilai Normal Kolesterol Total.
RI, Kemenkes (2022) Hipertensi: Musuh dalam selimut.
RI, Kemenekes (2022) Kolesterol.
Solikin and Muradi (2020) Hubungan Kadar Kolesterol Dengan Derajat Hipertensi Pada Pasien Hipertensi Di Puskesmas Sungai Jingah.
Utami, G.A.P.M. et al. (2024) Edukasi Mengenai Tanda Gejala, Penyebab dan Pencegahan Kolesterol di Apotek Syifa Banjarbaru.
Utami, S.N. and Lubis, S. (2021) Efektivitas Akreditasi Puskesmas Terhadap Kualitas Puskesmas Medan Helvetia.
(WHO), W.H.O. (2023) Hipertensi.
Zara, N. et al. (2023) Hiperkolesterolemia.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Endah Cahya Nisa Anastasya, Syarah Anliza, Adipura atmadja Egok, Citra Trisna, Basil Okeahiam
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal of Noncommunicable Diseases Prevention and Control applies the Creative Commons Attribution 4.0 International (CC BY) License, or other comparable licenses that allow free and unrestricted use to articles we publish. If you submit your manuscript for publication by the Journal of Noncommunicable Diseases Prevention and Control, you agree to have the CC BY license applied to your work. If your institution or funder requires your work or materials to be published under a different license or dedicated to the public domain - for example, Creative Commons 1.0 Universal (CC0) or Open Governmental License - this is permitted for those licenses where the terms are equivalent to or more permissive than CC BY.
